Immunome, Inc. (IMNM) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The next meaningful technical decision is likely to occur between support at 22.31 and resistance at 24.47. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.

📊 Technical Summary

Immunome, Inc. (IMNM) closed at 22.94 (-0.04%). The chart remains in a constructive trend regime, with price holding above both the 50-day and 200-day moving averages. 20-day momentum is positive at +2.18%; price is trading in the upper part of its roughly 52-week range (7.43–26.97); and ATR14 volatility is running near 4.43% of price. RSI(14) stands around 51.8, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure. The nearest decision zone is framed by support at 22.31 and resistance at 24.47. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Net income: -212.39M · EPS (basic): -0.65. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more